The recommended dosage of HARVONI in adults with genotype 1, 4, 5, or 6 HCV is one tablet (90 mg ledipasvir and 400 mg sofosbuvir) taken orally once daily with or without food [see CLINICAL PHARMACOLOGY]
You will usually need to take this medicine every day for either 12 or 24 weeks
For adults the recommended dose of Harvoni is one tablet containing 90 mg ledipasvir and 400 mg sofosbuvir once a day
Ledifos tablet is a composition of two drugs namely Ledipasvir and Sofosbuvir with a quantity of 90 mg and 400 mg respectively
HARVONI is a two-drug fixed-dose combination product that contains 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet
90% confidence interval: 80
Harvoni (brand) savings_outlined
Ledipasvir and sofosbuvir is sometimes given in combination with another medicine called ribavirin
IDDF2018-ABS-0111 Safety and efficacy of treatment with once-daily LEDIPASVIR/SOFOSBUVIR (90/400 MG) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment
Each film-coated tablet contains 90 mg ledipasvir and 400 mg sofosbuvir or 45 mg ledipasvir and 200 mg sofosbuvir